Research Grade Anti-Human CD262/TNFRSF10B/DR5 Antibody (TAS266)Anti-Human CD262/TNFRSF10B/DR5 Antibody (TAS266) ( HT348166 ) is a research-grade recombinant antibody targeting CD262 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Biosimilar | | Target | TRAILR2, TRAIL-R2, Death receptor 5, CD262, DR5, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9, TRAIL receptor 2, TRICK2, TNFRSF10B, KILLER, TNF-related apoptosis-inducing ligand receptor 2 | | Accession | O14763 | | Host species | Mammalian Cells | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-560-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-Human CD262/TNFRSF10B/DR5 Antibody (TAS266).
Примечание: |
|
